Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702,...
Photocure initiates arbitration against Asieris over unpaid USD 4.4 million milestone payment
The three major A-share indices turned positive collectively, innovative drugs rebounded, the Hang Seng Index rose nearly 3%, JD.com increased by over 7%, while crude oil and the shipping index plummeted
The three major A-share indices collectively closed higher, with over 4,200 stocks in the entire market in the green
Asieris Soars as China Approves World’s First Non-Invasive Treatment for Cervical Precancerous Lesions
CEVIRA, a non-invasive therapy for cervical precancerous lesions, approved in China by Asieris Pharmaceuticals.
EMA accepted marketing authorization app for Cevira by Asieris; collaboration with Photocure.